Postremission data
| Patient . | Idarubicin during induction . | Number of post-CR courses of mylotarg to date . | Interval (wks) between various courses . | Dose per course in mg/m2 . | Hematologic status . |
|---|---|---|---|---|---|
| 1 | No | 8 | 2*, 6, 5, 4, 6, 5, 4, 7 | 9 on all 8 courses | CR × 14 MOS + |
| 2 | No | 8 | 0, 4, 8, 4, 5, 4, 4, 4 | 9 on courses 1 and 2; 3 on remaining 6 courses | CR × 12 MOS + |
| 3 | No | 7 | 0, 5, 5, 5, 4, 6, 4, not given | 9 on courses 1 through 3; 6 on courses 4 and 5; 4.5 on remaining 2 courses | CR × 12 MOS + |
| 6 | No | 3 | 5, 4, 7 | 9 on all 3 courses | CR × 4 MOS + |
| 7 | No | 7 | 1, 4, 5, 4, 5, 6, 5 | 9 on all 7 courses | CR × 7 MOS + |
| 8 | Yes | 8 | 0, 4, 5, 4, 8, 4, 4, 4 | 9 on courses 1 through 5; 6 on courses 6 through 8 | CR × 11 MOS + |
| 9 | No | 7 | 1, 6, 4, 4, 5, 6, 5 | 9 on course 1; 5 on courses 2 through 7 | CR × 7 MOS + |
| 10 | No | 7 | 0, 4, 5, 4, 4, 4, 4 | 9 on all 7 courses | CR × 6 MOS + |
| 11 | Yes | 3 | 0, 5, 5 | 9 on all 3 courses | CR × 2 MOS + |
| 13 | No | 4 | 1, 5, 4, 4, not given | 9 on all 4 courses | CR × 5 MOS + |
| 14 | No | 5 | 1, 4, 5, 5, 5 | 9 on all 5 courses | CR × 4 MOS + |
| 15 | No | 3 | 0, 4, 4 | 9 on all 3 courses | CR × 2 MOS + |
| 16 | No | 1 | 1 | 7 | CR × 1 MO + |
| 17 | No | 2 | 2, 4 | 9 on both courses | CR × 2 MOS + |
| 18 | No | 2 | 1, 4 | 9 on both courses | CR × 1 MO + |
| 19 | No | 1 | 2 | 9 | CR × 1 MO + |
| Patient . | Idarubicin during induction . | Number of post-CR courses of mylotarg to date . | Interval (wks) between various courses . | Dose per course in mg/m2 . | Hematologic status . |
|---|---|---|---|---|---|
| 1 | No | 8 | 2*, 6, 5, 4, 6, 5, 4, 7 | 9 on all 8 courses | CR × 14 MOS + |
| 2 | No | 8 | 0, 4, 8, 4, 5, 4, 4, 4 | 9 on courses 1 and 2; 3 on remaining 6 courses | CR × 12 MOS + |
| 3 | No | 7 | 0, 5, 5, 5, 4, 6, 4, not given | 9 on courses 1 through 3; 6 on courses 4 and 5; 4.5 on remaining 2 courses | CR × 12 MOS + |
| 6 | No | 3 | 5, 4, 7 | 9 on all 3 courses | CR × 4 MOS + |
| 7 | No | 7 | 1, 4, 5, 4, 5, 6, 5 | 9 on all 7 courses | CR × 7 MOS + |
| 8 | Yes | 8 | 0, 4, 5, 4, 8, 4, 4, 4 | 9 on courses 1 through 5; 6 on courses 6 through 8 | CR × 11 MOS + |
| 9 | No | 7 | 1, 6, 4, 4, 5, 6, 5 | 9 on course 1; 5 on courses 2 through 7 | CR × 7 MOS + |
| 10 | No | 7 | 0, 4, 5, 4, 4, 4, 4 | 9 on all 7 courses | CR × 6 MOS + |
| 11 | Yes | 3 | 0, 5, 5 | 9 on all 3 courses | CR × 2 MOS + |
| 13 | No | 4 | 1, 5, 4, 4, not given | 9 on all 4 courses | CR × 5 MOS + |
| 14 | No | 5 | 1, 4, 5, 5, 5 | 9 on all 5 courses | CR × 4 MOS + |
| 15 | No | 3 | 0, 4, 4 | 9 on all 3 courses | CR × 2 MOS + |
| 16 | No | 1 | 1 | 7 | CR × 1 MO + |
| 17 | No | 2 | 2, 4 | 9 on both courses | CR × 2 MOS + |
| 18 | No | 2 | 1, 4 | 9 on both courses | CR × 1 MO + |
| 19 | No | 1 | 2 | 9 | CR × 1 MO + |
In each case the first number represents the weeks between complete remission (CR) date and start of the first postremission course.